OverviewSuggest Edit

Akers Biosciences develops, manufactures, and supplies rapid, point of care screening and testing products designed to bring healthcare information both rapidly and directly to the consumer or healthcare provider. The Company has advanced the science of diagnostics while responding to major shifts in healthcare through the development of several proprietary platform technologies. The Company's state-of-the-art rapid diagnostic assays can be performed virtually anywhere in minutes when time is of the essence. The Company has aligned with major healthcare companies and high volume medical products distributors to maximize product offerings, and to be a major worldwide competitor in diagnostics.
Now known as Akers Bio, we are dedicated to the development of time- and cost-efficient, single-use devices that can be utilized almost anytime, anywhere. We believe that our products facilitate more convenient and frequent point-of-care testing, which may ultimately save or improve the overall quality of individuals’ lives.

TypePublic
Founded1989
HQWest Deptford, NJ, US
Websiteakersbio.com

Latest Updates

Employees (est.) (Feb 2019)32
Revenue (FY, 2019)$1.6 M(-5%)
Share Price (Apr 2021)$2.5
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Akers Biosciences

Howard R. Yeaton

Howard R. Yeaton

Interim Chief Financial Officer
Christopher C. Schreiber

Christopher C. Schreiber

President and Chief Executive Officer, Director
Joshua Silverman

Joshua Silverman

Chairman
Bill J. White

Bill J. White

Independent Director
Gary M. Rauch

Gary M. Rauch

Vice President, Finance
Robert Schroeder

Robert Schroeder

Independent Director
Show more

Akers Biosciences Office Locations

Akers Biosciences has an office in West Deptford
West Deptford, NJ, US (HQ)
201 Grove Rd, Thorofare
Show all (1)

Akers Biosciences Financials and Metrics

Akers Biosciences Revenue

Akers Biosciences's revenue was reported to be $1.58 m in FY, 2019
USD

Net income (Q2, 2021)

(18.1m)

EBIT (Q2, 2021)

(18.3m)

Market capitalization (22-Apr-2021)

20.6m

Closing stock price (22-Apr-2021)

2.5

Cash (30-Jun-2021)

2.1m

EV

18.5m
Akers Biosciences's current market capitalization is $20.6 m.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

4.4m2.1m3.0m3.4m1.7m1.6m

Revenue growth, %

(52%)40%

Cost of goods sold

1.2m115.4k138.7k136.1k1.5m1.1m

Gross profit

3.3m2.0m2.8m3.2m127.3k478.7k
USDQ1, 2014

Financial Leverage

1.1 x
Show all financial metrics

Akers Biosciences Revenue Breakdown

Embed Graph

Akers Biosciences revenue breakdown by business segment: 99.9% from Product and 0.1% from Other

Akers Biosciences Cybersecurity Score

Cybersecurity ratingPremium dataset

B

88/100

SecurityScorecard logo

Akers Biosciences Online and Social Media Presence

Embed Graph

Akers Biosciences News and Updates

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Akers Biosciences, Inc. Merger

WILMINGTON, Del., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Akers Biosciences, Inc. (“Akers”) (NASDAQ GS: AKER) regarding possible breaches of fiduciary duties and other violations of law related to Akers’ agreement to merge with MYMD Pharmaceu…

SHAREHOLDER ALERT: WeissLaw LLP Investigates Akers Biosciences, Inc.

NEW YORK, Nov. 12, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) in connection with the Company's proposed merger with...

Akers Biosciences Announces $6.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Thorofare, New Jersey, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale of 1,207,744 shares of the Company’s common …

Akers Biosciences and Premas Biotech Announce Successful Expression of Coronavirus Antigens

Thorofare, New Jersey, April 08, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that its collaboration with Premas Biotech has successfully completed a second milestone, the successful expressio…

Akers Biosciences Announces $4.6 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Thorofare, New Jersey, April 07, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchas…

Akers Biosciences, Inc. Provides Notice of Proposed Settlement of Derivative Litigation

Thorofare, New Jersey, Jan. 17, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that it reached a settlement agreement to settle two shareholder derivative actions: Watts v. Gormally, et al., No.…
Show more

Akers Biosciences Frequently Asked Questions

  • When was Akers Biosciences founded?

    Akers Biosciences was founded in 1989.

  • Who are Akers Biosciences key executives?

    Akers Biosciences's key executives are Howard R. Yeaton, Christopher C. Schreiber and Joshua Silverman.

  • How many employees does Akers Biosciences have?

    Akers Biosciences has 32 employees.

  • Who are Akers Biosciences competitors?

    Competitors of Akers Biosciences include 19Labs, Cue and GoHealth Urgent Care.

  • Where is Akers Biosciences headquarters?

    Akers Biosciences headquarters is located at 201 Grove Rd, Thorofare, West Deptford.

  • Where are Akers Biosciences offices?

    Akers Biosciences has an office in West Deptford.

  • How many offices does Akers Biosciences have?

    Akers Biosciences has 1 office.